Delivery Order SPE2DB24D2010-SPE2DB24FZVB9
Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $18,817.49 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 17, 2025, with a completion date of July 18, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by...
- This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S pharmaceutical product to the Defense Logistics Agency (DLA). The $15,655.73 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2024 with a completion date of July 18, 2024. The contract is a delivery order under the agency's existing $999,999,999 Indefinite Delivery Contract (IDC) with Amerisourcebergen, which provides a broad range of...
- This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The $8,169.67 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 20, 2024 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The contract, valued at $10,836.57, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $21,859.56, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 18, 2024. The contract has an ultimate completion date of September 19, 2024 and is a firm fixed-price delivery order. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $30,205.02 and is a firm fixed-price delivery order type, with a completion date of September 5, 2024. The award date is September 4, 2024. This contract is not designated as a...
- This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 11, 2024, with a completion date of June 12, 2024. The contract has a ceiling value of $6,086.64 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
- This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, valued at $3,007.71, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 20, 2024. This award is part of a larger Indefinite Delivery...
- This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $13,861.26 and an ultimate completion date of June 20, 2024. It is not set aside for any specific business type. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $35,250.60, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...